ST
WX

Smithfield Trust’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Smithfield Trust’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,399
Closed -$60K – 880
2015
Q3 		$60K Hold
1,399
– – 0.01% 462
2015
Q2 		$59K Hold
1,399
– – 0.01% 490
2015
Q1 		$54K Sell
1,399
-50
-3% -$1.93K 0.01% 504
2014
Q4 		$49K Hold
1,449
– – 0.01% 513
2014
Q3 		$51K Sell
1,449
-2,215
-60% -$75.9K 0.01% 519
2014
Q2 		$121K Buy
+3,664
New +$125K 0.02% 414

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Smithfield Trust's WX Position: Q4 2015 in Review

Smithfield Trust sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 1,399 shares — an estimated $60K sold.

Smithfield Trust first reported a position in WX in Q2 2014 and held it in 6 quarters. The position peaked at $121K in Q2 2014. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Smithfield Trust reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Smithfield Trust sold 1,399 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $60K.
  • Smithfield Trust first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2014 and held it in 6 quarters.
  • Smithfield Trust's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $121K in Q2 2014.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Smithfield Trust's 13F filing for Q4 2015, filed 4 Feb 2016.